Pfizer’s RSV vaccine also known as Abrysvo is showing the potential to protect adults ages 18 to 59 who are at high risk of getting sick. Read this story
Pfizer’s RSV vaccine also known as Abrysvo is showing the potential to protect adults ages 18 to 59 who are at high risk of getting sick. Read this story
More from WWLP.com | Local News Digital First Hampden County Health Massachusetts National News Springfield Top Stories